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A 27 year old man with hereditary haemorrhagic telangiec-
tasia who developed progressive liver dysfunction underwent
living related right lobe transplantation. Pulmonary arterio-
graphy did not reveal arteriovenous malformation or
abnormal intrapulmonary venous channels. The postopera-
tive course was characterised by persistent hypoxaemia and
respiratory failure developed. On day 6, a massive
haemoptysis developed and the patient died shortly there-
after. The native liver showed a nodular pseudocirrhotic
transformation, with highly dilated and irregularly intercon-
nected vein-like or arterial-like structures in the fibrous septa.
Pathological examination of both lungs showed irregular
thickening of the wall of the arteries, secondary to eccentric
and/or concentric myointimal hyperplasia. This case sug-
gests that massive haemoptysis can develop even when
arteriovenous malformations are undetectable by pulmonary
arteriography, and it questions the role and the appropriate-
ness of living donor liver transplantation in high risk patients.
H
ereditary haemorrhagic telangiectasia (HHT) is an
autosomal dominant transmitted disorder, charac-
terised by angiodysplastic lesions involving the naso-
pharynx and oropharynx, gastrointestinal system, and
bronchial tree.1 2
The classic triad is recurrent epistaxis, mucocutaneous
telangiectasia, and hereditary transmission.3
Hepatic involvement is a rare manifestation of the disease
and its prevalence ranges from 8% to 31%.4 5 The most
frequent hepatic lesions are sinusoidal dilatation, fibrosis or
cirrhosis, hepatic artery aneurysms, and arterial–venous or
arterial–portal fistulas. Intrahepatic vascular shunts may lead
to right heart insufficiency or failure, as a consequence of
pulmonary hypertension.
Patients affected by HHT with liver involvement and left to
right intrahepatic shunt complicated by pulmonary hyperten-
sion and right sided heart failure can be successfully treated
by liver transplantation.6
CASE REPORT
A 27 year old man was admitted to the hospital for
consideration of liver transplantation with a diagnosis of
cryptogenic cirrhosis and hepatopulmonary syndrome.
The patient was well until the age of 18, when he was
submitted to brachial artery embolisation of an arteriovenous
malformation of the right elbow. He had repeated episodes of
epistaxis.
In February 1998, the patient developed rapidly worsening
dyspnoea, which needed treatment with oxygen (pulmonary
arterial pressure, 21/6 mmHg).
In October 1999, pulmonary and hepatic arteriography did
not reveal arteriovenous malformations in either the lungs or
the liver.
In May 2001, liver function tests and clinical conditions
quickly deteriorated (bilirubin, 4.6 mg/litre; international
normalised ratio, 1.6; albumin, 23 g/litre; and platelets,
55.000/mm3) and he was referred to our hospital. The patient
was in severe respiratory distress and he required treatment
with oxygen. The liver, which was tender and not pulsatile,
extended 3 cm below the right costal margin. Two vascular
malformations (2 cm in diameter) were noted on the skin
covering the nose. The splenic tip was not palpable.
An arterial blood sample showed hypoxaemia at rest
(partial oxygen pressure, 50 mmHg). Orthodeoxya was
absent. The diffusion capacity was 16 ml/minute/mmHg
(59% of predicted).
The patient was negative for hepatitis B surface antigen,
hepatitis C virus RNA, and anti-human immunodeficiency
virus antibodies.
HHT was diagnosed because of the presence of two
symptoms of the classic triad; that is, cutaneous vascular
malformation and recurrent epistaxis. Inheritance was
doubtful.
Although a review of previous pulmonary arteriography
did not show evidence of direct right to left shunts, the
pronounced dyspnoea with severe hypoxaemia, in the
absence of interstitial lung disease or pulmonary hyperten-
sion, were thought possibly to be related to microscopic
arteriovenous malformations. In June 2001, the patient was
submitted to living related (mother) right liver transplanta-
tion.
The immediate postoperative course was characterised by
persistent hypoxaemia. On day 2, the patient had an episode
of nasal and oropharynx bleeding. Fibre optic examination
showed telangiectasia in the nasal cavity and bleeding from
the left lower turbinate. On day 3, his clinical condition
worsened. A chest x ray showed bilateral pulmonary
atelectasia and pulmonary oedema. Fibre optic bronchoscopy
revealed blood clots in the left main bronchus.
On day 6, a massive haemoptysis developed and the patient
died shortly thereafter.
Pathological examination of the native liver showed a
grossly nodular surface (nodules ranged in size from 0.5 to
3 cm), with small spider-like vessels visible on the glissonian
capsule. The portal vein was extremely dilated, without
thrombi.
Histological examination of the liver parenchyma showed a
nodular pseudocirrhotic transformation, owing to the pre-
sence of extremely large fibrous septa irregularly dividing the
parenchyma into large near normal ‘‘macrolobules’’ contain-
ing numerous normal portal tracts and central veins (fig 1).
In the fibrous septa, irregular blood vessels could be
recognised, forming an ‘‘archipelago’’ encased in the fibrous
tissue, in which dilated vein-like or arterial-like structures
were present and irregularly interconnected. Some of these
vessels entered the parenchyma, simulating the features of
hepatoportal sclerosis (fig 1B).
Postmortem examination of the lungs showed a massive
bilateral pulmonary haemorrhage (fig 2). No thrombi of the
main pulmonary arteries were identified. The main airways
were occluded by blood and clots (fig 2). The pulmonary
veins were collapsed. Three main bronchial arteries (two
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branches for the main right bronchus and one branch for the
left main bronchus) were identified, and they were dilated
and tortuous.
The main histopathological findings were:
N Massive bronchial haemorrhage with secondary alveolar
flooding.
N The presence of a highly developed intrabronchial and
peribronchial vascular plexus constituted by large telan-
giectatic vessels.
N An interesting lesion of the main pulmonary peripheral
vessels was recognised: it was characterised by arteries
showing either irregular eccentric intimal thickening,
possibly related to previously organised thrombi or
myointimal hyperplasia of sparse small sized arteries (fig
3). Interlobular veins were greatly dilated. These features
were highly reminiscent of the lesions seen in arteriove-
nous malformations, or fistulas in other regions of the
human body.
N The cut surface of both lungs was diffusely haemorrhagic
and a specific site of the massive haemorrhage could not
be identified.
The hepatic graft showed mild steatosis and very sparse
mononuclear cell portal inflammatory infiltrates, with super-
Figure 2 Lungs and tracheobronchial tree viewed from behind,
after dissection of the pars membranacea of the trachea and of the
main left and right bronchi, showing large blood clots occluding the
airways.
Figure 1 Native liver histology: general architecture. (A) Extremely large fibrous septa entrapping near normal ‘‘hepatic macrolobules’’ containing
occasional portal tracts (P) and veins (V); large bile ducts (D) are irregularly embedded in the surrounding fibrous tissue. Chromotrope aniline blue
method; original magnification, 640. (B) Native liver histology: interesting features. Fibrous band containing small veins (Ve) and tangentially cut
arterial vessels (A). Greatly dilated sinusoids (S) are found in the surrounding parenchyma. The black arrow points to an irregular, thin walled vascular
space, directly abutting the hepatocyte cords. In addition, dilated vein-like vessels (V) are sparse among the hepatocyte cords. Haematoxylin and eosin
stained; original magnification, 640.
Figure 3 Massive alveolar
haemorrhage and the main vascular
lesions. (A) Eccentric intimal thickening
of the dilated medium arteries (arrows;
haematoxylin and eosin stained;
original magnification,6100) and (B)
myointimal hyperplasia of small sized
pulmonary arteries (arrows;




imposed haemorrhagic lesions of the centrilobular areas,
probably related to shock.
DISCUSSION
The clinical manifestations of HHT include vascular abnorm-
alities of the nose, skin, lung, brain, and gastrointestinal tract.1
Pulmonary arteriovenous malformations affect 5–15% of
patients with HHT. In some cases, standard chest x ray,
pulmonary angiography, or helical computed tomography
can demonstrate a typical mass with enlarged arteries and
veins or diffuse arteriovenous malformations.
In our patient, pulmonary angiography failed to demon-
strate such lesions.
Liver involvement owing to the presence of multiple
arteriovenous malformations or atypical cirrhosis is a rare
but important manifestation of HHT.3 4 7
Our patient showed fibrosis, pseudocirrhosis, and highly
dilated vein-like and arterial-like structures.
‘‘We are concerned about the role that liver transplanta-
tion could have played in the fatal outcome in our patient’’
Liver transplantation for HHT with decompensated end
stage liver disease and mild to moderate pulmonary
hypertension has been reported.3 6 8
These patients are usually classified as UNOS 2a transplant
recipients; in this group, the mortality rate from cadaveric
donors is 18%,6 9 compared with more than 50% from living
related donors.10
In this setting, many transplant centres do not agree to
perform living donor liver transplantation.
However, our patient had severe hypoxaemia, with a life
expectancy of less than three months, and an unpredictable
wait to receive a cadaveric liver.
In our patient, the cause of death was massive pulmonary
haemorrhage from the rupture of one or many angiodysplas-
tic bronchial lesions. This complication could not be predicted
from the angiographic study, which was unable to detect
arteriovenous malformations. The prevalence of pulmonary
arteriovenous malformations among patients with HHT has
been estimated to be 15–33%.11
Ference et al have reported the occurrence of pulmonary
haemorrhage in 11 (8%) of 143 patients with HHT not
submitted to liver transplantation.2
Although diffuse pulmonary haemorrhage can appear
during the natural history of HHT, we are concerned about
the role that liver transplantation could have played in the
fatal outcome in our patient.
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Take home messages
N We report a 27 year old man with hereditary
haemorrhagic telangiectasia who developed fatal
progressive liver dysfunction after living related right
lobe transplantation
N Pulmonary arteriography did not reveal arteriovenous
malformation or abnormal intrapulmonary venous
channels in this patient
N This case suggests that massive haemoptysis can
develop even when arteriovenous malformations are
undetectable by pulmonary arteriography
N It also questions the role and the appropriateness of
living donor liver transplantation in high risk patients
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